An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study
Clinical trial NCT05299931 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05299931
- Sponsor
- Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2026-06-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.